Press release

CooperSurgical® Acquires AEGEA Medical

TRUMBULL, Conn.--(BUSINESS WIRE)-- CooperSurgical announced today the acquisition of California-based, AEGEA Medical and its FDA-approved Mara™ Water Vapor

articleThe Cooper Companies, Inc.February 2, 20214/company/the-cooper-companies-inc/news/coopersurgicalr-acquires-aegea-medical-2021-02-02
CooperSurgical® Acquires AEGEA Medical

About this update from The Cooper Companies, Inc.

[{"type":"text","content":" TRUMBULL, Conn.--(BUSINESS WIRE)--\nCooperSurgical announced today the acquisition of California-based, AEGEA Medical and its FDA-approved Mara™ Water Vapor Ablation System. The acquisition builds on over 30 years of experience in women’s healthcare and complements CooperSurgical’s growing portfolio of medical products focused on clinic and practice-based women’s health.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210202005761/en/(Photo: Business Wire)\nMara is an endometrial ablation treatment that uses water vapor to safely treat heavy menstrual bleeding, specifically designed for use in the doctor’s office. Mara is a two-minute, in-office treatment that ablates the lining of the uterus, the source of heavy menstrual bleeding in women who have not reached menopause. Heavy menstrual bleeding, also known as menorrhagia, is a common condition about one-third of women seek treatment for during their lifetimes1. \n\nClinical study data demonstrates that Mara safely and effectively reduces heavy menstrual bleeding and improves a woman’s quality of life. Mara treats patients with myomas, large cavities and also provides post-ablation cavity access.\n\n“I’d like to thank Maria Sainz and her team, CEO of AEGEA, for her dedication to innovation in women’s health,” said Holly Sheffield, President of CooperSurgical. “The Mara Water Vapor Ablation System gives women a great option for a safe and convenient in-office procedure to help with what can often be a debilitating health issue.”\n\nMara Clinical Results\n\nOne year after treatment in an international, multi-center pivotal clinical trial that enrolled 155 women, 93% of women reported no to moderate bleeding2. Results also demonstrated the following:\n\n\n99% of patients experienced improvement in quality of life3\n\n\n91% of patients satisfied or very satisfied with procedure2,3\n\n\n93% said they would recommend it to a friend2\n\n \n\n\n\nFor clinical information or a demo of Mara, please visit coopersurgical.com.\n\nAbout CooperSurgical\n\nFor more than 30 years, CooperSurgical has been a leader in manufacturing and marketing a wide range of trusted and innovative brands that have assisted clinicians in advancing the standard of health care for women and families worldwide. CooperSurgical is a wholly-owned subsidia...

More updates from The Cooper Companies, Inc.